Ms. Sofiya Kagan reports

CHEELCARE ANNOUNCES UPSIZING OF NON-BROKERED PRIVATE PLACEMENT TO $3.0 MILLION

Cheelcare Inc., due to strong investor demand, has increased the size of its previously announced non-brokered private placement financing.

The company now intends to issue up to two million units of the company at a price of $1.50 per unit for aggregate gross proceeds of up to $3-million.

Each unit consists of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant will entitle the holder to purchase one additional share of the company at price of $2.25 per share for a period of two years from the date of closing.

The warrants are subject to an acceleration clause, whereby, if at any time prior to the expiry of the warrants, the closing price of the shares on the TSX Venture Exchange equals or exceeds $3 for any 10 consecutive trading days, the company may, at its option, accelerate the expiry date of the warrants to the date that is 30 days after the company provides notice of or issues a news release announcing such acceleration. Any warrants remaining unexercised after the accelerated expiry date will automatically expire and all rights of the holders of such warrants will terminate without compensation.

The company intends to use the proceeds from the offering for general working capital and corporate purposes, including continued product development and commercialization activities.

The offering is expected to include participation from certain directors, officers and insiders of the company. Such participation will constitute a related party transaction within the meaning of Multilateral Instrument 61-101, Protection of Minority Security Holders in Special Transactions. The company expects to rely on the exemptions from the formal valuation and minority shareholder approval requirements contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101, respectively, as neither the fair market value of the securities to be issued to, nor the consideration paid by, such insiders is expected to exceed 25 per cent of the company's market capitalization.

Completion of the offering is subject to the acceptance of the TSX Venture Exchange and other customary closing conditions. The units, and all securities underlying the units, will be subject to a statutory hold period of four months and one day from their date of issue in accordance with applicable securities laws.

The company may pay finders' fees in connection with certain subscriptions, in accordance with the policies of the TSX Venture Exchange.

About Cheelcare Inc.

Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic complex-rehab power wheelchair, Cheelcare combines engineering excellence with human-centred design to improve quality of life.

We seek Safe Harbor.